EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient

Kasumi Satoh iD, Manabu Okuyama, Hajime Nakae iD

Therapeutic Apheresis and Dialysis · 2024

DOI: 10.1111/1744-9987.14109 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Kasumi Satoh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Akita, Japan. Hauptthemen laut MEDLINE: Ascites. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AscitesHumansMaleCastleman DiseaseCell-Free SystemPrimary MyelofibrosisAged

Autor:innen und Institutionen

  • Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Akita, Japan.

ORCID-Profile: Kasumi Satoh, Hajime Nakae

Zitieren

APA

Satoh, K., Okuyama, M., & Nakae, H. (2024). Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14109

Vancouver

Satoh K, Okuyama M, Nakae H. Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14109

BibTeX
@article{Satoh2024,
  author = {Satoh, Kasumi and Okuyama, Manabu and Nakae, Hajime},
  title = {Potential risks of cell‐free concentrated ascites reinfusion therapy in TAFRO syndrome patient},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2024},
  doi = {10.1111/1744-9987.14109}
}
Kostenlos starten →